by Nicole Kuchinsky | Mar 31, 2016
Stem cell technology and reproductive medicine have always been tightly linked. After all, the early embryo is essentially a ball of stem cells. For this post, I will delve into a hot topic in reproductive medicine—three-person embryos. Similar to what we have seen...
by Mark Curtis | Mar 24, 2016
Welcome to your Update from the Clinic for the month of February. bluebird made its debut in the oncology market and treated its first patient with a chimeric antigen receptor (CAR) product targeting a novel antigen. Ziopharm enrolled its first patient in a study...
by Stacey Johnson | Mar 4, 2016
Last week, I wrote about Dr. Leon Bellan’s creative solution to engineering artificial blood vessels for lab-grown organs: cotton candy! As much as I was impressed with his out-of-the-box thinking, I also really liked the excellent video produced by Vanderbilt...
by Mark Curtis | Feb 22, 2016
Welcome to your update from the clinic for the month of January. It was a quiet month in the clinic. However, we did see some clearances for various clinical studies, including Fate’s ProTmune in GvHD and Pluristem’s PLX-R18 in hematopoietic recovery following bone...
by Stacey Johnson | Feb 5, 2016
According to the World Health Organization, there were 8.2 million cancer related deaths in 2012 so by my calculations, that’s over 22,000 each day. Cancer has been on my mind a lot this week, and not just because yesterday was #WorldCancerDay. On February 1st, the...
Comments